⌘K

Login Start Free

Home/Filings/4/0001209191-22-028726

4//SEC Filing

Longpre Lara 4

Accession 0001209191-22-028726

CIK 0001759425other

View on SEC.gov Company Profile

Filed

May 11, 8:00 PM ET

Accepted

May 12, 9:23 PM ET

Size

4.8 KB

Accession

0001209191-22-028726

Insider Transaction Report

Form 4

Period: 2022-05-10

Mirum Pharmaceuticals, Inc.MIRM

Chief Development Officer

Transactions

Award
Common Stock
2022-05-10$13.57/sh+1,454$19,725→ 96,452 total

Footnotes (1)

[F1]This Form 4 is being filed voluntarily to report the acquisition of 1,454 shares by the Reporting Person on May 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1

filerCIK 0001780347

Filing Metadata

Form type: 4
Filed: May 11, 8:00 PM ET
Accepted: May 12, 9:23 PM ET
Size: 4.8 KB

View on SEC.gov